Connect with us

Press Releases

Researchers Identify Second Gene That Causes Ocular Albinism




(Press Release) Scientists have discovered mutations in a second gene that can trigger ocular albinism, a genetic vision disorder.

The finding has major implications for better diagnosis of this disease. With a clearer understanding of the cause of the condition, scientists can move forward with research to improve vision for thousands of children with ocular albinism. The research, funded by The Vision of Children Foundation based in San Diego, CA, was led by Alejandra Young, assistant project scientist at UCLA Stein Eye Institute. Young worked under the leadership of Debora Farber, Karl Kirchgessner Foundation Distinguished Professor of Ophthalmology and director of the Retinal Biochemistry Laboratory.

Until recently, ocular albinism was believed to be caused solely by mutations in the OA1 gene (also known as GPR143), which provides instructions for making a protein that is involved in the pigmentation of the eyes and skin. This discovery was made in the early 1990s, also thanks to research funded by The Vision of Children Foundation.

“However, about 30 percent of patients with clinical manifestations of the disease had no mutations in the OA1 gene,” Young said. “This raised the possibility that a different gene could be responsible.”

Young and her colleagues analyzed DNA samples from 26 people who exhibit all the clinical characteristics of ocular albinism but do not have mutations in the OA1 gene. They compared these DNA samples to samples from subjects without a personal or family history of the disorder and consistently discovered several mutations in a gene called GNAI3. The results of this research study were published in the Sept. 8 edition of PLOS ONE, a multidisciplinary open access scientific journal.

Ocular albinism is a genetic eye disease that is transmitted through the X chromosome. It primarily affects the pigmentation in the eye, which is essential for normal vision. Affected individuals typically suffer from poor clarity of vision (reduced visual acuity), rapid and involuntary eye movements (nystagmus), eyes that do not look in the same direction (strabismus) and increased sensitivity to light (photophobia). They also have problems with the ability to create depth perception when combining vision from both eyes. This is due to abnormalities involving the optic nerves, which carry visual information from the eye to the brain. Incidence rates for this disorder are difficult to determine, partly due to frequent misdiagnosis. The most common form of Ocular Albinism is known as the Nettleship-Falls or type 1, which affects at least one in 60,000 males in the U.S., according to the National Institute of Health.


The classic signs and symptoms of this condition are much less common in females, who are carriers. Unlike some other forms of albinism, ocular albinism usually does not significantly affect the color of the skin and hair. Ocular albinism is just one of hundreds of genetic vision disorders. Millions of people around the world have uncorrectable genetic vision disorders, and even obtaining an accurate diagnosis is difficult, as there are limited facilities that can run the tests. Depending on the particular genetic disorder, testing can take up to two months to complete.

One of the few centers conducting such tests is the Medical Genetics Laboratory at Baylor College of Medicine in Houston. Dr. Richard Alan Lewis, a collaborator on this research, specializes in the study and diagnosis of hereditary eye disorders at Baylor. The Vision of Children Foundation was founded by Sam and Vivian Hardage in 1991, after their son was born with ocular albinism. At the time, there were no researchers anywhere in the world studying this genetic vision disorder, for which there are no treatments and no cures. The Hardages were determined to encourage scientific research to find a cure for this congenital condition.

Today, The Vision of Children Foundation is the foremost organization in the world supporting research for Ocular Albinism and related vision disorders. Over the past two decades, Vision of Children-funded researchers have conducted revolutionary work that has broad implications for vision science. Now, gene therapy and stem cell therapies, which seemed but a distant dream when the Foundation was founded, are becoming a reality.

Scientists funded by the foundation are exploring how to best use byproducts of patients’ own stem cells to replace defective DNA. This research is also taking place at UCLA Stein Eye Institute, under the direction of Farber.

“Our goal is to provide adequate funding to finish the quest at hand — eradicating ocular albinism,” Hardage said.

Scientists should then be able to utilize these proven techniques and procedures as a template to discover cures for a variety of genetic vision disorders, including oculocutaneous albinism and retinal degenerations.


“Through this research, we can foresee a day in the not-so-distant future when these and other vision diseases will be curable,” Hardage said.

The Vision of Children Foundation is a nonprofit organization dedicated to curing hereditary childhood blindness and other vision disorders, and improving the quality of life of visually impaired children and their families.



The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular